Challenges of antithrombotic therapy in TAVI

Learning Objectives

  • To identify the risk of peri-procedural and long-term thromboembolic complications in patients with valvular heart disease
  • To learn about peri-procedural strategies of antithrombotic therapy in TAVI
  • To learn about long-term strategies of antithrombotic therapy in TAVI

Presentations available when logged in:

  • Session objectives
  • What is the risk of thromboembolic complications during and after TAVI
  • Antithrombotic therapy before and during TAVI
  • What is the risk of early and late bleeding-complications
  • Antiplatelet and/or anticoagulation therapy after TAVI
  • Abnormal leaflet motion after TAVI: thromboembolic precursors or imaging artefacts?
  • Session evaluation and key learnings